Livewire Live – content round-up
On 9 September 2025, some of Australia’s most experienced professional investors assembled to debate critical …
We want to ensure you get the right experience for you.
Discover the Allan Gray difference. Learn more about our Funds including performance and download offer documents.
The information contained in this section is for adviser and wholesale investor use only.
The Allan Gray Australia Funds are available for investment by New Zealand retail clients.
To comply with New Zealand law, our website provides information only about Allan Gray Australia Funds. We do not provide advice to New Zealand retail clients.
You are about to enter Allan Gray Australia.
If you are looking for Allan Gray South Africa, please click here.
US persons are not generally permitted to invest in the Allan Gray Australia Funds. However, we will accept applications from US persons who are genuine residents of Australia, New Zealand or South Africa.
Quarterly Review – March 2021In this extract from our March 2021 Quarterly Commentary, Julian Morrison, CFA, our Head of Research Relationships and National Key Accounts, reviews the performance of the Allan Gray Australia Funds. Click here to read the full Quarterly Commentary.
The Australian sharemarket had a decent quarter, with the S&P/ ASX 300 Accumulation Index up 4.2%. The Allan Gray Australia Equity Fund (Class A) returned 7.6% during the same period, outperforming its S&P/ASX 300 benchmark by 3.4%.
In a continuation from the prior quarter, the Fund’s overweight position in the Materials sector was the largest positive contributor to relative returns from a sector perspective. But this exposure has been very different from the benchmark, with the most positively contributing holdings including Incitec Pivot, Nufarm and Sims.
Energy companies such as Woodside Petroleum and Oil Search have remained appealing and the Fund continues to hold these shares today.
Elsewhere, the Fund’s underweight position in Healthcare and Information Technology contributed strongly to relative performance, as those sectors fared poorly during the quarter. We have long held the view that some of the stocks in these sectors have been priced with excessively optimistic expectations, and remain wary of the risk of overvaluation.
We continue to see great opportunity in discounting the obvious and investing in areas that have been overlooked or discarded by other investors. These opportunities are currently among longer-standing companies that have a proven track record and a sound basis to exist, but which for some reason are unappealing to most investors. Despite the strong performance in the last quarter, the recovery to date has been relatively immaterial in the context of the preceding underperformance by the Fund and similar past experiences. We see significant latent unrealised value in the Fund versus the market and thus remain cautiously optimistic regarding future long-term prospects.
The Allan Gray Australia Balanced Fund outperformed its composite benchmark by 4.0% for the March quarter.
The Fund had 68% in shares at quarter end, although about 7% of the global share exposure is reduced through the use of exchange-traded derivatives, which allows for some protection in those periods where market indices fall. Stock selection in both Australian and global shares added to relative returns.
The Fund held around 21% in fixed income securities and a 5% exposure to gold through an exchange-traded fund at quarter end. The fixed income allocation has remained significantly shorter in duration than the benchmark – at below one year versus around eight for the benchmark. This contributed to outperformance for the March quarter, with government bond yields generally rising during this period. The fixed income portion of the Fund remains more defensively positioned than the benchmark in terms of both relative and absolute returns, in the event interest rates rise further. As with the Equity Fund, we believe potential portfolio value relative to the market is significant and we continue to manage for risk with a long-term, valuation-driven perspective.
The Allan Gray Australia Stable Fund outperformed its cash rate benchmark by 2.0% for the March quarter.
The performance of the Stable Fund is driven by the performance of our favoured Australian share holdings and the decision on how much is invested in shares versus cash. Having added to share exposure during the weakness of the prior quarter, the Fund took advantage of the strength of the March quarter to lighten some of our stronger positions.
As at the end of March, the Fund had around 35% invested in ASX-listed securities, with the remainder in cash and money market investments. This can be seen in the graph below, which shows our allocation between cash and shares over time.
The overall recovery in the sharemarket during the last quarter fails to highlight the significant divergence that has built up over time between different categories of stocks. Some popular stocks and sectors are priced at levels that in our view are far too optimistic. We therefore remain focused on avoiding those areas and the risks that come with excessive valuation. Instead, the shares held in the Fund will be those we have assessed as most attractively priced and where risk of permanent capital loss is low.

Source: Allan Gray, Bloomberg, as at 31 March 2021.
Julian Morrison holds a Bachelor of Arts (Honours – University of Sheffield) and the Chartered Financial Analyst designation.
Equity Trustees Limited ABN 46 004 031 298, AFSL No. 240975 is the responsible entity and issuer of units in the Allan Gray Australia Equity Fund ARSN 117 746 666, Allan Gray Australia Balanced Fund ARSN 615 145 974, and Allan Gray Australia Stable Fund ARSN 149 681 774 (Allan Gray Funds). Equity Trustees is a subsidiary of EQT Holdings Limited (ABN 22 607 797 615), a publicly listed company on the Australian Securities Exchange (ASX: EQT). Allan Gray Australia Pty Limited ABN 48 112 316 168, AFSL No. 298487 is the investment manager of the Allan Gray Funds. Neither Allan Gray Australia Pty Limited, Equity Trustees Limited nor any of their related parties, their employees or directors, provide any warranty of accuracy or reliability in relation to such information or accepts any liability to any person who relies on it.
Past performance is not a reliable indicator of future performance. There are risks involved with investing and the value of your investments may fall as well as rise. This represents Allan Gray Australia Pty Limited’s views at a point in time and may provide reasoning or rationale on why we bought or sold a particular security for the Allan Gray Funds or our clients. We may take the opposite view/position from that stated, as our view may change. This insight is not an offer or recommendation, constitutes general advice or information only and not personal financial product, tax, legal, or investment advice. It does not take into account the specific investment objectives, financial situation or individual needs of any particular person and may not be appropriate for you. We have tried to ensure that the information here is accurate in all material respects, but cannot guarantee that it is.
You should consider the relevant Product Disclosure Statement (PDS) before acquiring, holding or disposing of units in an Allan Gray Fund. The PDSs, Target Market Determinations (TMDs) and Minimum Disclosure Documents for South African investors (MDDs) can be obtained from our Forms & Documents page. Each TMD sets out who an investment in the relevant Allan Gray or Orbis Funds might be appropriate for and the circumstances that trigger a review of the TMD.
Managed investment schemes are generally medium to long-term investments. They are traded at prevailing prices and the value of units may go down as well as up. There are risks with investing the Fund and there is no guarantee of repayment of capital or return on your investment. Subject to relevant disclosure documents, managed investments can engage in borrowing and securities lending. A schedule of fees and charges is available in the PDS.